주요 콘텐츠로 건너뛰기

귀하의 브라우저가 완벽하게 지원되지 않습니다. 옵션이 있는 경우 최신 버전으로 업그레이드하거나 Mozilla Firefox, Microsoft Edge, Google Chrome 또는 Safari 14 이상을 사용하세요. 가능하지 않거나 지원이 필요한 경우 피드백을 보내주세요.

이 새로운 경험에 대한 귀하의 의견에 감사드립니다.의견을 말씀해 주세요 새 탭/창에서 열기

Elsevier
엘스비어와 함께 출판

Profile

Baik-Lin Seong

BS

Baik-Lin Seong

Yonsei University, Republic of Korea

Baik-Lin Seong, PhD, is Professor of Yonsei University College of Medicine, and Director General of Vaccine Innovative Technology ALliance (VITAL)-Korea. He served as a member of the Presidential Advisory Council of Science & Technology of Korean Government (2021-2022) and the Scientific Advisory Board of International Vaccine Institute (IVI) (2018-2022). He was the chair of the COVID-19 Vaccine Pan-Government Strategic Plan of Korean Government. With a view to ensure equitable access of effective vaccines to LMICs, he works on developing a low-cost bacterial production of VLP/nanoparticle vaccines against RSV, norovirus, highly pathogenic avian influenza, and flaviviruses including Japanese Encephalitis, Zika, and West Nile viruses